Insulet removes certain Omnipod 5 Pods, FDA announces

On March 12, Insulet (PODD) sent all affected customers a letter recommending they not use pods from affected lots, FDA reported. On April 10, Insulet sent all affected customers an updated letter expanding the list of affected Pod lots and providing additional details on this issue to clarify that the Pod defect may not be detectable by users. Insulet is also sending targeted communications to users who activate a Pod from an impacted lot with information on Pod discontinuation, the FDA noted in an updated recall notice that is current as of April 29.